Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial assessing long-term adjunctive lacosamide in adults with partial-onset seizures; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Pharma SA | Conditions: Epilepsy, Partial-onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2020-08-13